{"success":true,"data":{"pressRelease":{"id":"67860","rtpr_id":"nPn8jBJCda","ticker":"WGS","exchange":"NASDAQ","all_tickers":["WGS"],"title":"WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action Lawsuit - Investors Should Contact SueWallSt","author":"PR Newswire","published_at":"2026-06-18T14:09:01.064Z","article_body":"WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action Lawsuit - Investors Should Contact SueWallSt\n\nPR Newswire\n\nNEW YORK, June 18, 2026\n\nDeadline Alert: Understanding Lead Plaintiff Selection Under the PSLRA in the\nGeneDx Holdings Corp. Securities Class Action Where Investors Lost $33.42 Per\nShare\n\nNEW YORK, June 18, 2026 /PRNewswire/ -- IMPORTANT DATE: August 3, 2026.\nInvestors who purchased GeneDx Holdings Corp. (NASDAQ: WGS) securities between\nApril 16, 2025 and May 4, 2026 and wish to seek appointment as lead plaintiff\nmust file a motion by this date. Start your claim now before the deadline\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4714096-11&h=4111919558&u=https%3A%2F%2Fsuewallst.com%2Flawsuits%2Fgenedx-holdings-corp-class-action-lawsuit-wgs%3Fprid%3D187565%26wire%3D4&a=Start+your+claim+now+before+the+deadline)\n. You may also contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com\n(mailto:jlevi@SueWallSt.com)  or (888) SueWallSt.\n\nWGS shares fell $33.42 per share, a decline of 49.20%, after the Company\ndisclosed a $31.2 million impairment loss tied to its Fabric Genomics\nacquisition and slashed full-year revenue guidance by approximately $65\nmillion.\n\nWhat Is a Lead Plaintiff?\n\nUnder the Private Securities Litigation Reform Act of 1995, the court appoints\none investor or small group of investors to serve as lead plaintiff. The lead\nplaintiff directs the litigation on behalf of the entire class. In the WGS\naction, the lead plaintiff will oversee claims that GeneDx made materially\nfalse statements about the Fabric Genomics acquisition between April 16, 2025\nand May 4, 2026.\n\nLead Plaintiff Facts\n\n * The lead plaintiff is typically the investor with the largest financial\ninterest in the case, meaning the greatest documented losses from\npurchasing WGS stock during the Class Period\n * There is no minimum loss requirement to apply; any investor who purchased\nduring the Class Period may seek appointment\n * Lead plaintiffs do not pay any fees or costs out of pocket; counsel works on a\ncontingency basis approved by the court\n * Serving as lead plaintiff does not increase your individual recovery but\nprovides direct oversight of case strategy and settlement decisions\n * Investors who do not seek lead plaintiff status remain class members and may\nstill participate in any recovery\n * The court evaluates competing motions and selects the most adequate plaintiff\nunder the PSLRA's statutory criteria\nPost-Deadline Procedures\n\nAfter August 3, 2026, the court will consolidate any competing lead plaintiff\nmotions and evaluate which applicant satisfies the PSLRA's requirements. This\nprocess typically takes several weeks. Once appointed, the lead plaintiff\nselects lead counsel, and the case proceeds to the pleading stage.\n\nAbsent Class Member Rights\n\nInvestors who do not apply for lead plaintiff retain their rights as absent\nclass members. No action is required before August 3, 2026 to preserve your\nability to participate in any future settlement or judgment. The deadline\napplies only to those seeking to represent the class.\n\n\"The lead plaintiff process is designed to ensure the class is represented by\nshareholders with substantial interests in the outcome. In the GeneDx case,\nwhere investors saw nearly half their investment wiped out in a single day,\nselecting an engaged lead plaintiff with significant losses is particularly\nimportant.\" -- Joseph E. Levi, Esq.\n\nFind out if you qualify to recover losses\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4714096-11&h=650868660&u=https%3A%2F%2Fsuewallst.com%2Flawsuits%2Fgenedx-holdings-corp-class-action-lawsuit-wgs%3Fprid%3D187565%26wire%3D4&a=Find+out+if+you+qualify+to+recover+losses)\n or contact Joseph E. Levi, Esq. at (888) SueWallSt.\n\nSueWallSt | Top 50 Securities Firm | (888) SueWallSt | www.zlk.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4714096-11&h=3608193770&u=http%3A%2F%2Fwww.zlk.com%2F&a=www.zlk.com)\n\nFrequently Asked Questions About the WGS Lawsuit\n\nQ: What is a lead plaintiff and why does it matter? A: A lead plaintiff is\nthe investor appointed by the court to represent the entire class. Lead\nplaintiffs are typically investors with the largest documented losses. Being\nappointed does not increase individual recovery but gives direct oversight of\nhow the case is run.\n\nQ: How do I know if I lost enough money to be the lead plaintiff? A: There is\nno minimum loss threshold. Courts appoint the investor with the largest\nprovable loss who is willing and able to represent the class adequately.\nContact SueWallSt before August 3, 2026 to evaluate.\n\nQ: What documents do I need to make a claim? A: Brokerage statements or trade\nconfirmations showing purchase dates, share quantities, prices paid, and any\nsubsequent sale dates and prices.\n\nQ: What if I missed the lead plaintiff deadline? A: The deadline applies only\nto investors seeking lead plaintiff appointment. Class members who miss it can\nstill participate in any settlement or recovery.\n\nQ: What does it cost me to participate? A: Nothing. Securities class actions\nare handled on a pure contingency basis. No upfront fees, no retainer, no\nout-of-pocket costs.\n\nQ: What happens after I contact SueWallSt? A: An attorney will review your\ntrading history at no cost and provide an initial assessment of your potential\nrecovery.\n\nCONTACT:\n\nSueWallSt\nJoseph E. Levi, Esq.\n33 Whitehall Street, 27th Floor\nNew York, NY 10004\njlevi@SueWallSt.com (mailto:jlevi@SueWallSt.com)\nTel: (888) SueWallSt\nFax: (212) 363-7171\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/wgs-shareholder-alert-genedx-holdings-corp-securities-class-action-lawsuit---investors-should-contact-suewallst-302803907.html\n(https://www.prnewswire.com/news-releases/wgs-shareholder-alert-genedx-holdings-corp-securities-class-action-lawsuit---investors-should-contact-suewallst-302803907.html)\n\nSOURCE SueWallSt.com\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1812443/suewallst-logo-1_Logo.jpg?id=OA2723101\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn8jBJCda","title":"WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action Lawsuit - Investors Should Contact SueWallSt","author":"PR Newswire","ticker":"WGS","created":"2026-06-18T14:09:01.064Z","tickers":["WGS"],"exchange":"NASDAQ","article_body":"WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action Lawsuit - Investors Should Contact SueWallSt\n\nPR Newswire\n\nNEW YORK, June 18, 2026\n\nDeadline Alert: Understanding Lead Plaintiff Selection Under the PSLRA in the\nGeneDx Holdings Corp. Securities Class Action Where Investors Lost $33.42 Per\nShare\n\nNEW YORK, June 18, 2026 /PRNewswire/ -- IMPORTANT DATE: August 3, 2026.\nInvestors who purchased GeneDx Holdings Corp. (NASDAQ: WGS) securities between\nApril 16, 2025 and May 4, 2026 and wish to seek appointment as lead plaintiff\nmust file a motion by this date. Start your claim now before the deadline\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4714096-11&h=4111919558&u=https%3A%2F%2Fsuewallst.com%2Flawsuits%2Fgenedx-holdings-corp-class-action-lawsuit-wgs%3Fprid%3D187565%26wire%3D4&a=Start+your+claim+now+before+the+deadline)\n. You may also contact Joseph E. Levi, Esq. at jlevi@SueWallSt.com\n(mailto:jlevi@SueWallSt.com)  or (888) SueWallSt.\n\nWGS shares fell $33.42 per share, a decline of 49.20%, after the Company\ndisclosed a $31.2 million impairment loss tied to its Fabric Genomics\nacquisition and slashed full-year revenue guidance by approximately $65\nmillion.\n\nWhat Is a Lead Plaintiff?\n\nUnder the Private Securities Litigation Reform Act of 1995, the court appoints\none investor or small group of investors to serve as lead plaintiff. The lead\nplaintiff directs the litigation on behalf of the entire class. In the WGS\naction, the lead plaintiff will oversee claims that GeneDx made materially\nfalse statements about the Fabric Genomics acquisition between April 16, 2025\nand May 4, 2026.\n\nLead Plaintiff Facts\n\n * The lead plaintiff is typically the investor with the largest financial\ninterest in the case, meaning the greatest documented losses from\npurchasing WGS stock during the Class Period\n * There is no minimum loss requirement to apply; any investor who purchased\nduring the Class Period may seek appointment\n * Lead plaintiffs do not pay any fees or costs out of pocket; counsel works on a\ncontingency basis approved by the court\n * Serving as lead plaintiff does not increase your individual recovery but\nprovides direct oversight of case strategy and settlement decisions\n * Investors who do not seek lead plaintiff status remain class members and may\nstill participate in any recovery\n * The court evaluates competing motions and selects the most adequate plaintiff\nunder the PSLRA's statutory criteria\nPost-Deadline Procedures\n\nAfter August 3, 2026, the court will consolidate any competing lead plaintiff\nmotions and evaluate which applicant satisfies the PSLRA's requirements. This\nprocess typically takes several weeks. Once appointed, the lead plaintiff\nselects lead counsel, and the case proceeds to the pleading stage.\n\nAbsent Class Member Rights\n\nInvestors who do not apply for lead plaintiff retain their rights as absent\nclass members. No action is required before August 3, 2026 to preserve your\nability to participate in any future settlement or judgment. The deadline\napplies only to those seeking to represent the class.\n\n\"The lead plaintiff process is designed to ensure the class is represented by\nshareholders with substantial interests in the outcome. In the GeneDx case,\nwhere investors saw nearly half their investment wiped out in a single day,\nselecting an engaged lead plaintiff with significant losses is particularly\nimportant.\" -- Joseph E. Levi, Esq.\n\nFind out if you qualify to recover losses\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4714096-11&h=650868660&u=https%3A%2F%2Fsuewallst.com%2Flawsuits%2Fgenedx-holdings-corp-class-action-lawsuit-wgs%3Fprid%3D187565%26wire%3D4&a=Find+out+if+you+qualify+to+recover+losses)\n or contact Joseph E. Levi, Esq. at (888) SueWallSt.\n\nSueWallSt | Top 50 Securities Firm | (888) SueWallSt | www.zlk.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4714096-11&h=3608193770&u=http%3A%2F%2Fwww.zlk.com%2F&a=www.zlk.com)\n\nFrequently Asked Questions About the WGS Lawsuit\n\nQ: What is a lead plaintiff and why does it matter? A: A lead plaintiff is\nthe investor appointed by the court to represent the entire class. Lead\nplaintiffs are typically investors with the largest documented losses. Being\nappointed does not increase individual recovery but gives direct oversight of\nhow the case is run.\n\nQ: How do I know if I lost enough money to be the lead plaintiff? A: There is\nno minimum loss threshold. Courts appoint the investor with the largest\nprovable loss who is willing and able to represent the class adequately.\nContact SueWallSt before August 3, 2026 to evaluate.\n\nQ: What documents do I need to make a claim? A: Brokerage statements or trade\nconfirmations showing purchase dates, share quantities, prices paid, and any\nsubsequent sale dates and prices.\n\nQ: What if I missed the lead plaintiff deadline? A: The deadline applies only\nto investors seeking lead plaintiff appointment. Class members who miss it can\nstill participate in any settlement or recovery.\n\nQ: What does it cost me to participate? A: Nothing. Securities class actions\nare handled on a pure contingency basis. No upfront fees, no retainer, no\nout-of-pocket costs.\n\nQ: What happens after I contact SueWallSt? A: An attorney will review your\ntrading history at no cost and provide an initial assessment of your potential\nrecovery.\n\nCONTACT:\n\nSueWallSt\nJoseph E. Levi, Esq.\n33 Whitehall Street, 27th Floor\nNew York, NY 10004\njlevi@SueWallSt.com (mailto:jlevi@SueWallSt.com)\nTel: (888) SueWallSt\nFax: (212) 363-7171\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/wgs-shareholder-alert-genedx-holdings-corp-securities-class-action-lawsuit---investors-should-contact-suewallst-302803907.html\n(https://www.prnewswire.com/news-releases/wgs-shareholder-alert-genedx-holdings-corp-securities-class-action-lawsuit---investors-should-contact-suewallst-302803907.html)\n\nSOURCE SueWallSt.com\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1812443/suewallst-logo-1_Logo.jpg?id=OA2723101\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-06-18T14:09:01.114365076Z","server_sent_at_ms":1781791741114},"received_at":"2026-06-18T14:09:01.173Z","source_url":"https://www.prnewswire.com/news-releases/wgs-shareholder-alert-genedx-holdings-corp-securities-class-action-lawsuit---investors-should-contact-suewallst-302803907.html"},"analysis":{"id":"57277","press_release_id":"67860","analysis_json":{"industry":{"label":"Life Sciences Tools & Services","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"SueWallSt issued a shareholder alert soliciting lead plaintiffs for a securities class action against GeneDx Holdings Corp. (WGS).\n\nThe release cites a 49.2% stock drop following a $31.2 million impairment loss on the Fabric Genomics acquisition and a $65 million cut to full-year revenue guidance.\n\nInvestors who purchased shares between April 16, 2025, and May 4, 2026, are urged to file motions by August 3, 2026, to seek appointment as lead plaintiff. This is a law-firm marketing notice, not an issuer disclosure.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{"customDimensions":{"guidance_cut":"$65 million","impairment_loss":"$31.2 million","share_price_decline":"$33.42","share_price_decline_pct":"49.20%"}},"quotedText":"The lead plaintiff process is designed to ensure the class is represented by shareholders with substantial interests in the outcome. In the GeneDx case, where investors saw nearly half their investment wiped out in a single day, selecting an engaged lead plaintiff with significant losses is particularly important.","namedEntities":{"people":[{"name":"Joseph E. Levi","role":"Attorney at SueWallSt"}],"products":[],"companies":[{"name":"GeneDx Holdings Corp.","ticker":"WGS","relationship":"defendant"},{"name":"SueWallSt","relationship":"plaintiff law firm"},{"name":"Fabric Genomics","relationship":"acquired entity"}],"dollarAmounts":[{"amount":"$33.42","context":"per-share decline in WGS stock price"},{"amount":"$31.2 million","context":"impairment loss tied to Fabric Genomics acquisition"},{"amount":"$65 million","context":"reduction in full-year revenue guidance"}]},"materialImpact":{"score":1,"reasoning":"This is a plaintiff law-firm solicitation issued by SueWallSt (Zucker Law Group) to recruit lead plaintiffs for a securities class action. It contains no new disclosure from the issuer, no court certification, and no settlement. Per guardrails, such solicitations are low-impact noise."},"tickerRelevance":{"others":[],"primary":"WGS"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"context":"routine lead-plaintiff deadline reminder","tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"SueWallSt issued a shareholder alert soliciting lead plaintiffs for a securities class action against GeneDx Holdings Corp. (WGS).\n\nThe release cites a 49.2% stock drop following a $31.2 million impairment loss on the Fabric Genomics acquisition and a $65 million cut to full-year revenue guidance.\n\nInvestors who purchased shares between April 16, 2025, and May 4, 2026, are urged to file motions by August 3, 2026, to seek appointment as lead plaintiff. This is a law-firm marketing notice, not an issuer disclosure.","key_figures":{"customDimensions":{"guidance_cut":"$65 million","impairment_loss":"$31.2 million","share_price_decline":"$33.42","share_price_decline_pct":"49.20%"}},"named_entities":{"people":[{"name":"Joseph E. Levi","role":"Attorney at SueWallSt"}],"products":[],"companies":[{"name":"GeneDx Holdings Corp.","ticker":"WGS","relationship":"defendant"},{"name":"SueWallSt","relationship":"plaintiff law firm"},{"name":"Fabric Genomics","relationship":"acquired entity"}],"dollarAmounts":[{"amount":"$33.42","context":"per-share decline in WGS stock price"},{"amount":"$31.2 million","context":"impairment loss tied to Fabric Genomics acquisition"},{"amount":"$65 million","context":"reduction in full-year revenue guidance"}]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-06-18T14:10:08.857Z","global_importance":15,"audience_relevance":10,"importance_components":{"context":"routine lead-plaintiff deadline reminder","tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":41329,"modelName":"george-droid-qwen-72b"}}